Related Experiment Video
Updated: Sep 10, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Unmet Needs in Hemophilia: A Narrative Review
Rabindra K Jena1, Tuphan K Dolai2, Jina Bhattacharyya3
1Professor and Bone Marrow Transplant Physician, Department of Clinical Hematology, Srirama Chandra Bhanja Medical College and Hospital, Cuttack, Odisha, India, Corresponding Author, Orcid: https://orcid.org/0000-0001-9525-3016.
None:
This review assesses the current landscape of hemophilia management, focusing on identifying unmet clinical needs. Hemophilia, a rare genetic bleeding disorder, requires continuous and comprehensive care to improve patients' life expectancy and quality of life (QoL). Despite advancements in treatment, challenges persist, including suboptimal bleed protection with current prophylactic options, the development of inhibitory alloantibodies, and the resulting joint damage leading to hemophilic arthropathy (HA). Additionally, the review highlights the significant physical and psychological burden on patients, impacting their education, employment, and overall QoL. Addressing these unmet needs through innovative therapies, improved access to care, and individualized treatment strategies is crucial for enhancing outcomes and reducing the overall burden of hemophilia, particularly in high-prevalence regions like India.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

